Emergo Therapeutics Raises $12 Million in Venture Funding, Led by REX Health Ventures
RALEIGH, N.C. – May 23, 2018 – Emergo Therapeutics has raised $12 million in a Series A funding from a group of investors led by REX Health Ventures (RHV). Other major investors include Wolfpack Investor Network (WIN), Carolina Angel Network (CAN) and the Venture Capital Multiplier Fund at Hatteras Venture Partners.